Flexural or Inverse Psoriasis in a Patient With Hidradenitis Suppurativa Receiving Treatment With Infliximab

Statistics

Case and research letter

Aparición de psoriasis flexural o invertida en una paciente con hidrosadenitis supurativa en tratamiento con infliximab

A. Nuño-Gonzáleza,

Corresponding author

almudenanuno@hotmail.com

Corresponding author.

, L. Dehesab, C. Ricottib, F. Kerdelb

a Unidad de Dermatología, Hospital Universitario Fundación Alcorcón, Madrid, Spain

b Florida Academic Dermatology Center, University of Miami Hospital, Florida, USA

Read

13947

Times
was read the article

3911

Total PDF

10036

Total HTML

Share statistics

Article information

ISSN: 15782190
Original language: English

DOI:10.1016/j.adengl.2011.12.007

The statistics are updated each day

Year/Month	Html	Pdf	Total

2025 6	141	35	176
2025 5	230	37	267
2025 4	199	33	232
2025 3	165	32	197
2025 2	195	31	226
2025 1	106	43	149
2024 12	99	39	138
2024 11	111	65	176
2024 10	81	46	127
2024 9	106	29	135
2024 8	117	66	183
2024 7	103	41	144
2024 6	114	51	165
2024 5	88	45	133
2024 4	92	37	129
2024 3	94	39	133
2024 2	104	41	145
2024 1	100	37	137
2023 12	79	29	108
2023 11	89	33	122
2023 10	86	44	130
2023 9	82	25	107
2023 8	81	18	99
2023 7	89	49	138
2023 6	91	31	122
2023 5	108	41	149
2023 4	92	33	125
2023 3	83	40	123
2023 2	67	37	104
2023 1	66	39	105
2022 12	84	52	136
2022 11	63	32	95
2022 10	34	42	76
2022 9	32	34	66
2022 8	26	50	76
2022 7	27	32	59
2022 6	36	29	65
2022 5	60	43	103
2022 4	96	41	137
2022 3	119	68	187
2022 2	121	45	166
2022 1	87	43	130
2021 12	67	62	129
2021 11	84	69	153
2021 10	91	68	159
2021 9	70	43	113
2021 8	67	42	109
2021 7	60	61	121
2021 6	68	48	116
2021 5	59	37	96
2021 4	93	71	164
2021 3	120	49	169
2021 2	74	38	112
2021 1	59	37	96
2020 12	65	36	101
2020 11	51	34	85
2020 10	60	23	83
2020 9	71	24	95
2020 8	61	26	87
2020 7	49	18	67
2020 6	30	34	64
2020 5	28	14	42
2020 4	26	23	49
2020 3	38	39	77
2020 2	7	7	14
2020 1	2	8	10
2019 12	4	7	11
2019 11	4	8	12
2019 10	0	4	4
2019 9	4	6	10
2019 8	4	8	12
2019 7	4	28	32
2019 6	4	50	54
2019 5	5	137	142
2019 4	2	73	75
2019 3	0	23	23
2019 2	2	22	24
2019 1	0	13	13
2018 12	2	19	21
2018 11	2	2	4
2018 10	1	0	1
2018 9	4	8	12
2018 8	0	17	17
2018 7	0	15	15
2018 6	0	15	15
2018 5	0	11	11
2018 4	0	5	5
2018 3	1	13	14
2018 2	63	16	79
2018 1	70	13	83
2017 12	70	12	82
2017 11	52	9	61
2017 10	36	5	41
2017 9	52	15	67
2017 8	91	25	116
2017 7	89	25	114
2017 6	97	47	144
2017 5	94	14	108
2017 4	91	20	111
2017 3	61	13	74
2017 2	35	12	47
2017 1	34	19	53
2016 12	77	11	88
2016 11	101	21	122
2016 10	104	15	119
2016 9	124	34	158
2016 8	100	17	117
2016 7	65	8	73
2016 6	18	19	37
2016 5	16	8	24
2016 4	15	4	19
2016 3	17	3	20
2016 2	11	3	14
2016 1	11	1	12
2015 12	11	2	13
2015 11	13	2	15
2015 10	17	12	29
2015 9	22	1	23
2015 8	21	3	24
2015 7	140	12	152
2015 6	90	10	100
2015 5	125	26	151
2015 4	127	26	153
2015 3	744	18	762
2015 2	486	17	503
2015 1	63	16	79
2014 12	71	30	101
2014 11	50	5	55
2014 10	67	13	80
2014 9	55	6	61
2014 8	106	12	118
2014 7	93	4	97
2014 6	91	8	99
2014 5	54	8	62
2014 4	27	6	33
2014 3	15	15	30
2014 2	19	8	27
2014 1	9	9	18
2013 12	20	10	30
2013 11	14	12	26
2013 10	19	13	32
2013 9	12	10	22
2013 8	14	19	33
2013 7	10	21	31
2013 6	16	15	31
2013 5	16	14	30
2013 4	18	17	35
2013 3	19	18	37
2013 2	48	11	59
2013 1	154	11	165
2012 12	80	10	90

Show all

Indexed in:

Follow us:

Statistics

Indexed in:

Follow us:

Statistics

Subscribe to our newsletter